PPD Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 jan 1970 @ 01:00):

PPD, Inc. provides drug development services to the biopharmaceutical industry worldwide. The company operates through Clinical Development Services and Laboratory Services segments...

Stats
Dagens volum	1.87M
Gjennomsnittsvolum	1.44M
Markedsverdi	0.00
EPS	$0.440 ( Q3 \| 2021-10-28 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 0
ATR14	$0.151 (0.32%)

ACOR -24.02%

ACRX 7.50%

ADMP 0.85%

ADMS 0.00%

AGRX 0.71%

AKAN -3.24%

ALIM -0.72%

AMPH -4.55%

AMYT 0.00%

ANIP -0.61%

AQST -6.73%

ASRT 0.40%

ATNX 0.00%

AVDL -2.17%

AYTU -3.09%

BFRI -2.00%

BGXX 8.21%

CLVR 0.00%

COLL 1.02%

CPIX -1.31%

CRDL -1.73%

CRON -1.93%

CYTH -3.40%

DCPH 0.00%

DERM -3.65%

DRRX 0.82%

DVAX -0.85%

EGRX -2.68%

EMBC -1.96%

EMBCV -9.33%

EOLS 0.88%

ESPR 6.08%

EVOK -4.54%

FLGC -4.82%

FLXN 0.00%

GHSI -1.68%

HCM 2.51%

HROW 0.91%

HUGE -3.75%

IMCC -3.78%

INCR 1.99%

IRWD 0.77%

ITCI -2.93%

IXHL 0.34%

JUPW 11.76%

KALA -1.97%

KIN 0.11%

KMDA -1.20%

LNTH -0.77%

NBIX 1.15%

NEPT 0.00%

NLTX 1.45%

OGI 0.32%

OPTN 1.91%

ORGO -2.50%

PAHC 1.97%

PCRX 0.45%

PETQ 1.13%

PLXP 0.00%

PPD 0.00%

PROC -0.32%

PRPH -3.35%

PTPI -3.48%

RDHL -0.62%

RDUS 0.65%

REPH -0.48%

RGC -5.03%

RMTI -3.98%

SCTL 0.92%

SCYX -4.01%

SIGA -0.82%

SISI -13.85%

SNDL 0.53%

SNOA 7.35%

SSIC -2.79%

SUPN -0.90%

SXTC 0.90%

THTX 0.70%

TKNO -10.22%

TLGT -13.85%

TLRY 0.90%

TXMD 5.90%

TYHT -3.90%

UPC 3.75%

VTRS -0.56%

ZYNE 2.36%

Insider Trading

Date	Person	Action	Amount	type
2021-12-08	Carlyle Group Inc.	Sell	55 722 733	Common Stock
2021-12-08	H&f Corporate Investors Vii, Ltd.	Sell	157 138	Common Stock
2021-12-08	Johnston David Michael	Buy	33 228	Stock Options (Right to Buy)
2021-12-08	Johnston David Michael	Buy	25 522	Common Stock
2021-12-08	Johnston David Michael	Sell	151 747	Stock Options (Right to Buy)

INSIDER POWER
0.00
Last 98 transactions
Buy: 2 703 151 \| Sell: 89 993 839

Volum Korrelasjon

Lang: 0.17 (neutral)

Kort: 0.34 (neutral)

Signal:(54.867) Neutral

PPD Inc Korrelasjon

10 Mest positive korrelasjoner
TLND	0.918
STAY	0.897
MDCA	0.895
LMRKO	0.883
LMRKP	0.883
ECHO	0.877
GAINM	0.876
CNBKA	0.874
AMTBB	0.868
DVCR	0.865

10 Mest negative korrelasjoner
TLGT	-0.86
BOWXU	-0.838

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

PPD Inc Korrelasjon - Valuta/Råvare

-0.44
( neutral )

-0.33
( neutral )

-0.77
( moderate negative )

0.30
( neutral )

0.95
( very strong )

0.17
( neutral )

PPD Inc Økonomi

Annual	2020
Omsetning:	$4.68B
Bruttogevinst:	$1.80B (38.42 %)
EPS:	$0.350

FY	2020
Omsetning:	$4.68B
Bruttogevinst:	$1.80B (38.42 %)
EPS:	$0.350

FY	2019
Omsetning:	$4.03B
Bruttogevinst:	$1.62B (40.24 %)
EPS:	$0.161

FY	2018
Omsetning:	$3.75B
Bruttogevinst:	$1.47B (39.32 %)
EPS:	$0.300

Financial Reports:

No articles found.

PPD Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

PPD Inc

PPD, Inc. provides drug development services to the biopharmaceutical industry worldwide. The company operates through Clinical Development Services and Laboratory Services segments. It offers clinical development services, including product development and consulting, early development, Phases II-IV clinical trial management, accelerated enrollment, peri- and post-approval, and medical communications services. The company also provides laboratory services comprising bioanalytical, biomarker, vaccine science, good manufacturing practice, and central laboratory services. It serves pharmaceutical, biotechnology, medical device, and government organizations, as well as other industry participants. The company was founded in 1985 and is headquartered in Wilmington, North Carolina.